ArticleDigestive diseases and sciences2015

Clinical Experience of the Use of CT-P13, a Biosimilar to Infliximab in Patients with Inflammatory Bowel Disease: A Case Series.

Yun-Seong Kang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.